Early aggressive cholesterol-lowering after stroke with clot removal
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether quickly starting an aggressive cholesterol-lowering treatment after a stroke improves recovery. It is for people who are about to have a procedure to remove a large blood clot from their brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a stroke caused by a large blood clot in the front part of your brain.
- You are scheduled to have a procedure to remove the clot within 24 hours of your symptoms starting.
- You have not had a stroke before that left you with significant disability.
- You are not allergic to a type of cholesterol-lowering medicine called PCSK9 inhibitors.
- You do not have severe kidney or liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
This trial studies whether starting a cholesterol-lowering medicine called a PCSK9 inhibitor early after a heart attack can improve heart health and outcomes. It focuses on people who had a recent heart-artery procedure to fix the blockage in the left anterior descending (LAD) artery.
This trial tests if adding a PCSK9 inhibitor (a newer cholesterol-lowering medicine) to standard care helps people who had a stroke from a large artery blockage and had a clot-removal procedure. It may lower bad cholesterol further and reduce the risk of another stroke.
This trial tests whether giving a PCSK9 inhibitor (a type of cholesterol-lowering medicine) early after a stroke can improve recovery and lower 'bad' cholesterol. It is for people who have had a non-cardioembolic stroke (not from a heart problem) caused by hardening of the arteries.
This trial tests whether a PCSK9 inhibitor (a drug that lowers cholesterol) can help people who recently had a stroke caused by narrowing of an artery inside the skull. It aims to see if the drug can prevent more strokes and improve recovery.
This trial tests whether a cholesterol-lowering medication (PCSK9 inhibitor) can help prevent further strokes in people who have recently had a stroke or mini-stroke due to a narrowed artery in the brain. It is for adults 30 to 80 years old who meet specific health criteria.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.